KPL-301 for Subjects With Giant Cell Arteritis
Clinical trial NCT03827018 · COMPLETED
Trial details
- NCT number
- NCT03827018
- Sponsor
- Kiniksa Pharmaceuticals, Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-20
- Primary completion
- 2020-08-13
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.